Metraipolis › archive › dc_0212aef29cc5

Evolutionary characterization of whole-genome doubling across human cancers — arXiv:2611.01897

Source
arXiv (en)
Original
https://arxiv.org/abs/2611.01897
License (as archived)
CC0-1.0
Archived
2026-11-03T19:07:06.354Z
SHA-256 of the archived text
88feb0c721a61153d432bd2af31b7eae64fc3c0f79b8e0554df2dfc191fa944f
Stable URL of this page
https://metraipolis.com/documento/dc_0212aef29cc5

How to cite

Evolutionary characterization of whole-genome doubling across human cancers — arXiv:2611.01897 — arXiv (en), https://arxiv.org/abs/2611.01897 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_0212aef29cc5 (Metraipolis archive dc_0212aef29cc5, sha256 88feb0c721a61153d432bd2af31b7eae64fc3c0f79b8e0554df2dfc191fa944f)
BibTeX
@misc{dc0212aef29cc5,
  title = {Evolutionary characterization of whole-genome doubling across human cancers — arXiv:2611.01897},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2611.01897},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_0212aef29cc5; sha256 88feb0c721a61153d432bd2af31b7eae64fc3c0f79b8e0554df2dfc191fa944f},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2611.01897. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Whole-genome doubling (WGD) is common across human cancers and is associated with tumour progression and adverse clinical outcomes. However, how genome-doubled tumours evolve across diverse cancer types remains poorly understood. Here we characterize WGD-associated tumour evolution by integrating genomic analyses of 41,332 tumours from 12 cancer types with evolutionary timing and multi-omic data. Several canonical driver mutations generally preceded WGD when both occurred, as did the onset of homologous recombination deficiency-associated mutagenesis. Notably, post-WGD chromosome-arm losses showed substantially weaker cancer-type dependence than pre-WGD losses, with 61-75% less variance explained by cancer type. Beyond chromosomal evolution, WGD+ tumours showed reduced interferon-response and HLA antigen-presentation programmes linked to epigenetic remodelling, without disproportionate enrichment of genetic immune-escape alterations. Our findings highlight WGD as a recurrent evolutionary transition associated with altered chromosomal evolution and epigenetically linked immune adaptation across cancers.

Tema degli esploratori: scienze della vita e salute (elenco arXiv q-bio.PE, nuovi lavori del giorno).
Categorie arXiv: Genomics (q-bio.GN) ; Populations and Evolution (q-bio.PE).
Pagina del lavoro: https://arxiv.org/abs/2611.01897 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-11-03T18:23:52.762Z dalla pagina https://arxiv.org/list/q-bio.PE/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).